|
|
||||||||
Animal: DNA Viruses |
Centre de recherche du Centre hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montréal, Québec, CanadaH2L 4M11
Département de microbiologie et immunologie de lUniversité de Montréal, Montréal, Québec, Canada2
Institut de recherche en biotechnologie, 6100 ave Royalmount, Montréal, CanadaH4P 2R23
INRS-IAF Université du Québec, Laval, Québec, CanadaH7N 4Z34
Author for correspondence: Yves Langelier (at Centre de recherche du Centre hospitalier de lUniversité de Montréal). Fax +1 514 412 7590. e-mail yves.langelier{at}umontreal.ca
The R1 subunit of herpes simplex virus (HSV) ribonucleotide reductase, which in addition to its C-terminal reductase domain possesses a unique N-terminal domain of about 400 amino acids, is thought to have an additional, as yet unknown, function. Here, we report that the full-length HSV-2 R1 has an anti-apoptotic function able to protect cells against death triggered by expression of R1(
2357), an HSV-2 R1 subunit with its first 357 amino acids deleted. We further substantiate the R1 anti-apoptotic activity by showing that its accumulation at low level could completely block apoptosis induced by TNF-receptor family triggering. Activation of caspase-8 induced either by TNF or by Fas ligand expression was prevented by the R1 protein. As HSV R1 did not inhibit cell death mediated by several agents acting via the mitochondrial pathway (Bax overexpression, etoposide, staurosporine and menadione), it is proposed that it functions to interrupt specifically death receptor-mediated signalling at, or upstream of, caspase-8 activation. The N-terminal domain on its own did not exhibit anti-apoptotic activity, suggesting that both domains of R1 or part(s) of them are necessary for this new function. Evidence for the importance of HSV R1 in protecting HSV-infected cells against cytokine-induced apoptosis was obtained with the HSV-1 R1 deletion mutants ICP6
and hrR3. These results show that, in addition to its ribonucleotide reductase function, which is essential for virus reactivation, HSV R1 could contribute to virus propagation by preventing apoptosis induced by the immune system.
This article has been cited by other articles:
![]() |
M. Filippova, M. M. Johnson, M. Bautista, V. Filippov, N. Fodor, S. S. Tungteakkhun, K. Williams, and P. J. Duerksen-Hughes The Large and Small Isoforms of Human Papillomavirus Type 16 E6 Bind to and Differentially Affect Procaspase 8 Stability and Activity J. Virol., April 15, 2007; 81(8): 4116 - 4129. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chabaud, A. M.-J. Sasseville, S. M. Elahi, A. Caron, F. Dufour, B. Massie, and Y. Langelier The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function J. Gen. Virol., February 1, 2007; 88(2): 384 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bosnjak, M. Miranda-Saksena, D. M. Koelle, R. A. Boadle, C. A. Jones, and A. L. Cunningham Herpes Simplex Virus Infection of Human Dendritic Cells Induces Apoptosis and Allows Cross-Presentation via Uninfected Dendritic Cells J. Immunol., February 15, 2005; 174(4): 2220 - 2227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filippova, L. Parkhurst, and P. J. Duerksen-Hughes The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis J. Biol. Chem., June 11, 2004; 279(24): 25729 - 25744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Patrone, E. Percivalle, M. Secchi, L. Fiorina, G. Pedrali-Noy, M. Zoppe, F. Baldanti, G. Hahn, U. H. Koszinowski, G. Milanesi, et al. The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection J. Gen. Virol., December 1, 2003; 84(12): 3359 - 3370. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Brune, M. Nevels, and T. Shenk Murine Cytomegalovirus m41 Open Reading Frame Encodes a Golgi-Localized Antiapoptotic Protein J. Virol., November 1, 2003; 77(21): 11633 - 11643. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |